Pharmacologic Characterization of LTGO-33, a Selective Small Molecule Inhibitor of the Voltage-Gated Sodium Channel NaV1.8 with a Unique Mechanism of Action
John M. Gilchrist(Atara Biotherapeutics (United States)), Bryan D. Moyer(Atara Biotherapeutics (United States))
Cited by 38
Related Papers
Na<sub>v</sub>1.1 Modulation by a Novel Triazole Compound Attenuates Epileptic Seizures in Rodents
|ACS Chemical Biology|2014|44
Non-invasive diagnosis of early pulmonary disease in PECAM-deficient mice using infrared pulse oximetry
|Experimental and Molecular Pathology|2009|12
Microhemorrhage is an early event in the pulmonary fibrotic disease of PECAM-1 deficient FVB/n mice
|Experimental and Molecular Pathology|2014|9